Sharon X. Wen

Array ( [id] => 17698281 [patent_doc_number] => 11372002 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-28 [patent_title] => Assays for determining plasma kallikrein system biomarkers [patent_app_type] => utility [patent_app_number] => 15/030811 [patent_app_country] => US [patent_app_date] => 2014-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 35 [patent_no_of_words] => 22365 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19652408 [patent_doc_number] => 12174188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-24 [patent_title] => Methods of identifying subjects responsive to treatment for type 1 diabetes and compositions for treating the same [patent_app_type] => utility [patent_app_number] => 15/027757 [patent_app_country] => US [patent_app_date] => 2014-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 14384 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15027757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10255005 [patent_doc_number] => 20150140002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA' [patent_app_type] => utility [patent_app_number] => 14/511975 [patent_app_country] => US [patent_app_date] => 2014-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 39003 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9989135 [patent_doc_number] => 09034332 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-05-19 [patent_title] => 'Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment' [patent_app_type] => utility [patent_app_number] => 14/507368 [patent_app_country] => US [patent_app_date] => 2014-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 88148 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14507368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10001469 [patent_doc_number] => 09045548 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-06-02 [patent_title] => 'Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment' [patent_app_type] => utility [patent_app_number] => 14/500233 [patent_app_country] => US [patent_app_date] => 2014-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 84018 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14500233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10281676 [patent_doc_number] => 20150166673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'HUMAN TARGETS' [patent_app_type] => utility [patent_app_number] => 14/500397 [patent_app_country] => US [patent_app_date] => 2014-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 55761 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14500397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9950560 [patent_doc_number] => 08999341 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-04-07 [patent_title] => 'Targeting rare human PCSK9 variants for cholesterol treatment' [patent_app_type] => utility [patent_app_number] => 14/490160 [patent_app_country] => US [patent_app_date] => 2014-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 84033 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14490160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10026123 [patent_doc_number] => 09068012 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-06-30 [patent_title] => 'Targeting rare human PCSK9 variants for cholesterol treatment' [patent_app_type] => utility [patent_app_number] => 14/490091 [patent_app_country] => US [patent_app_date] => 2014-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 84020 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14490091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9989134 [patent_doc_number] => 09034331 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-05-19 [patent_title] => 'Targeting rare human PCSK9 variants for cholesterol treatment' [patent_app_type] => utility [patent_app_number] => 14/490112 [patent_app_country] => US [patent_app_date] => 2014-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 84006 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 204 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14490112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10281675 [patent_doc_number] => 20150166672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'Precision Medicine By Targeting Rare Human PCSK9 Variants for Cholesterol Treatment' [patent_app_type] => utility [patent_app_number] => 14/490175 [patent_app_country] => US [patent_app_date] => 2014-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 55807 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14490175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9839789 [patent_doc_number] => 20150031870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 14/487932 [patent_app_country] => US [patent_app_date] => 2014-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 152 [patent_no_of_words] => 73069 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14487932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12367278 [patent_doc_number] => 09957294 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-01 [patent_title] => Compositions and methods for analyzing histidine phosphorylation [patent_app_type] => utility [patent_app_number] => 14/485578 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 25 [patent_no_of_words] => 9801 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14485578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11075743 [patent_doc_number] => 20160272707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'VSTM5 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER, INFECTIOUS DISEASES AND IMMUNE RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 15/021239 [patent_app_country] => US [patent_app_date] => 2014-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 126640 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9936891 [patent_doc_number] => 08986694 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-03-24 [patent_title] => 'Targeting human nav1.7 variants for treatment of pain' [patent_app_type] => utility [patent_app_number] => 14/472698 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 145920 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14472698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9936888 [patent_doc_number] => 08986691 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-03-24 [patent_title] => 'Method of treating atopic dermatitis or asthma using antibody to IL4RA' [patent_app_type] => utility [patent_app_number] => 14/472828 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 109493 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14472828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9943631 [patent_doc_number] => 08992927 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-03-31 [patent_title] => 'Targeting human NAV1.7 variants for treatment of pain' [patent_app_type] => utility [patent_app_number] => 14/472685 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 145585 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14472685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9922319 [patent_doc_number] => 08980273 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-03-17 [patent_title] => 'Method of treating atopic dermatitis or asthma using antibody to IL4RA' [patent_app_type] => utility [patent_app_number] => 14/472818 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 109397 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14472818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10954831 [patent_doc_number] => 20140357854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'NUCLEIC ACID ENCODING ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 14/459844 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 152 [patent_no_of_words] => 73129 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10954828 [patent_doc_number] => 20140357850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'NUCLEIC ACID ENCODING ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 14/459777 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 152 [patent_no_of_words] => 73204 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10954832 [patent_doc_number] => 20140357853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'NUCLEIC ACID ENCODING ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 14/459768 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 152 [patent_no_of_words] => 73204 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459768 [rel_patent_id] =>[rel_patent_doc_number] =>)